OSBPL9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.6999000000002E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.60010000000077E-05 |
Normal-vs-Stage2 |
7.044800E-04 |
Normal-vs-Stage3 |
1.101850E-02 |
Normal-vs-Stage4 |
5.080000E-01 |
Stage1-vs-Stage2 |
9.485800E-01 |
Stage1-vs-Stage3 |
8.634000E-01 |
Stage1-vs-Stage4 |
4.317000E-01 |
Stage2-vs-Stage3 |
8.462000E-01 |
Stage2-vs-Stage4 |
4.336000E-01 |
Stage3-vs-Stage4 |
4.553200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.20780000000009E-05 |
Normal-vs-AfricanAmerican |
2.20350000001979E-06 |
Normal-vs-Asian |
2.786400E-02 |
Caucasian-vs-AfricanAmerican |
1.892250E-01 |
Caucasian-vs-Asian |
8.201200E-01 |
AfricanAmerican-vs-Asian |
8.412600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.3810000000225E-06 |
Normal-vs-Female |
1.159980E-02 |
Male-vs-Female |
5.759300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.755940E-02 |
Normal-vs-Extreme_Weight |
3.62820000000541E-05 |
Normal-vs-Obese |
1.77627999999874E-05 |
Normal-vs-Extreme_Obese |
1.118350E-01 |
Normal_Weight-vs-Extreme_Weight |
3.420800E-01 |
Normal_Weight-vs-Obese |
3.917600E-01 |
Normal_Weight-vs-Extreme_Obese |
7.518400E-01 |
Extreme_Weight-vs-Obese |
8.819200E-01 |
Extreme_Weight-vs-Extreme_Obese |
2.376800E-01 |
Obese-vs-Extreme_Obese |
2.192600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.644000E-03 |
Normal-vs-Age(41-60Yrs) |
2.059900E-03 |
Normal-vs-Age(61-80Yrs) |
3.97500000004491E-06 |
Normal-vs-Age(81-100Yrs) |
3.024600E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.934200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.271000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.872200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.940000E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.402600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.718200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
4.09550000002312E-06 |
Normal-VS-Type2 PRCC |
6.199700E-04 |
Normal-VS-KIRP CIMP |
3.130200E-02 |
Normal-VS-Unclassified PRCC |
2.775400E-03 |
Type1 PRCC-VS-Type2 PRCC |
8.931200E-01 |
Type1 PRCC-VS-KIRP CIMP |
6.342400E-01 |
Type1 PRCC-VS-Unclassified PRCC |
3.380400E-01 |
Type2 PRCC-VS-KIRP CIMP |
7.954200E-01 |
Type2 PRCC-VS-Unclassified PRCC |
5.302400E-01 |
KIRP CIMP-VS-Unclassified PRCC |
9.421200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.15499999997493E-06 |
Normal-vs-N1 |
3.323600E-01 |
Normal-vs-N2 |
2.056200E-01 |
N0-vs-N1 |
1.102970E-01 |
N0-vs-N2 |
4.076600E-01 |
N1-vs-N2 |
7.942200E-01 |
|
|